Notice Number: NOT-FD-13-005

Key Dates
Release Date: May 22, 2013

Issued by
Food and Drug Administration (FDA)

Purpose

This Notice is to inform potential applicants that the FDA is revising Section II. Award Information, the Funds Available and the Anticipated Number of Awards information in RFA-FD-13-016, "In Vitro Release Tests for Topical Dermatological Products (UO1).

CURRENT LANGUAGE INDICATES: The number of awards is contingent upon FDA appropriations and the submission of a sufficient number of meritorious applications.

FDA/CDER intends to fund up to one (1) award, corresponding to a total of $500,000, for fiscal year 2013. Future year amounts will depend on annual appropriations, the availability of funds and project performance.

NEW LANGUAGE REFLECTS: The number of awards is contingent upon FDA appropriations and the submission of a sufficient number of meritorious applications.

FDA/CDER intends to fund up to two (2) awards, not to exceed $500,000 in total costs (direct and indirect) per award for fiscal year 2013.

The second award may be given based on the scientific merit of the proposal. Future year amounts will depend on annual appropriations, the availability of funds and project performance.

Inquiries

Please direct all inquiries to:

Gladys Melendez-Bohler,
Grants Management Officer/Specialist
Food and Drug Administration
5630 Fishers Lane, Rm. 2032, HFA 500
Rockville, MD 20857
301-827-7175
gladys.bohler@fda.hhs.gov